Red Star Capital Bureau reported on February 18 that a number of senior executives of listed pharmaceutical companies resigned intensively.
According to incomplete statistics from the Red Star Capital Bureau, in the past month (January 17-February 17), as many as 29 listed company executives have had personnel changes.
On January 18, Liu Pharmaceutical Group (603368SH) announced that due to work changes, Chen Hong applied for resignation as vice president of the company, and still served as a director of the company after his resignation. On the same day, nominated by the president of the company, it was agreed to appoint Liang Zhen as the vice president of the company.
On January 18, Northeast Pharmaceutical (000597SZ) announced that Cai Yang applied for resignation as secretary of the board of directors of the company due to personal reasons, and will no longer hold any position in the company after his resignation.
On January 18, Jincheng Pharmaceutical (300233SZ) announced that the board of directors of the company received a written resignation report submitted by Fu Miaoqing, director and vice president, Fu Miaoqing applied for resignation as a director, vice president and member of the strategy committee of the sixth board of directors for personal reasons, and still served as the chairman of Guangdong Jincheng Jinsu Pharmaceutical, a holding subsidiary of the company. On the same day, the board of directors agreed to appoint Wang Hui and Zhang Xicheng as vice presidents of the company.
On January 19, Pien Tze Huang (600436SH) announced that Chen Jipeng resigned from the board of supervisors and chairman of the board of supervisors of the company due to work adjustments. After his resignation, Chen Jipeng will no longer hold any position in the company.
On January 22, Hisun Pharmaceutical (600267SH) announced that Lu Xinghai applied for resignation as senior vice president of the company for personal reasons. Hisun Pharmaceutical said that the company will make alternative arrangements for its work.
On January 23, Frontier Biotech (688221SH) announced that Wen Honghai resigned as a non-independent director of the third board of directors of the company due to personal work changes, and also resigned as a member of the audit committee of the third board of directors. After his resignation, Wen Honghai no longer held any position in the company.
On January 27, Guangji Pharmaceutical (000952SZ) announced that Hu Mingfeng, director and chief financial officer of the company, applied for resignation as the company's chief financial officer due to work changes. After his resignation, Mr. Hu Mingfeng continued to serve as a director of the Company. On the same day, nominated by the chairman, it was agreed to appoint Xiong Yi as the company's chief financial officer.
On January 27, Maider Medical (688310.)SH) announced that Wu Yifan resigned as a non-independent director of the fourth board of directors of the company due to personal work arrangements. After Wu Yifan resigns from the above positions, he will no longer hold any position in the company.
On January 30, Yifeng Pharmacy (603939SH) announced that Tian Wei applied for resignation as vice president of the company for personal reasons, and after his resignation, he will no longer hold other positions in the company. On the same day, nominated by Gao Yi, president of the company, it was agreed to appoint Hu Jianxia as the company's assistant president.
On January 31, Kindike (688670.)SH) announced that Fan Changyong, deputy general manager and secretary of the board of directors of the company, resigned for personal reasons and will not serve in the company after his resignation.
On February 1, Meinian Health (002044SZ) announced that due to work adjustments, Tan Xu applied for resignation as a supervisor of the eighth board of supervisors of the company. After his resignation, Tan Xu no longer held any position in the company.
On February 1, Panlong Pharmaceutical (002864SZ) announced that due to work arrangements, Xie Xiaolin resigned as general manager of the company, and Zhang Zhihong and Wu Jie resigned as deputy general managers of the company. Zhang Pingping resigned as a director of the company for personal reasons. The board of directors approved the appointment of Hu Qifei as the new general manager of the company.
On February 2, West Point Pharmaceutical (301130SZ) announced that due to work changes, Meng Yonghong will no longer serve as the secretary of the board of directors of the company, and will continue to serve as the company's director and deputy general manager after leaving office.
On February 2, Tailong Pharmaceutical (600222SH) announced that due to work adjustments, Feng Haiyan applied for resignation as secretary of the board of directors and deputy general manager of the company, and will still hold other positions in the company after his resignation. Nominated by the chairman of the company, it was agreed to appoint Li Nianyun as the secretary of the board of directors of the company.
On February 2, MGI (688114SH) announced that Fang Hao applied for resignation as a non-independent director of the company for personal reasons, and will no longer hold any position in the company after his resignation.
On February 3, Gongdong Medical (605369SH) announced that due to personal reasons, Pan Lei applied for resignation as the company's chief financial officer, and he will continue to hold other positions in the company after resigning as chief financial officer. Prior to the appointment of a new chief financial officer, the company's director and general manager, Mr. Zhong Wei, will perform the duties of the chief financial officer.
On February 3, Nuotai Biotech (688076SH) announced that Gu Haitao, the company's deputy general manager and core technical personnel, and Mr. Yang Jie, the core technical personnel, resigned for personal reasons and no longer held any positions in the company after their resignation. After the company's management decided to study and decide, Zhang Yu and Liu Ting were newly identified as the company's core technical personnel.
On February 5, Tongce Medical (600763SH) announced that Wang Shouyang, an independent director of the company, submitted a written resignation report for personal reasons and no longer held any position in the company.
On February 5, ABA Chemical (300261SZ) announced that Mao Haifeng applied for resignation from the position of director and deputy general manager of the company for personal reasons, and Mr. Mao Haifeng will continue to serve as the head of the company's ** chain center after his resignation.
On February 5, Hualan shares (301093SZ) announced that Jiao Baoan intends to resign as the head of the company's audit department from February 7, 2024 due to personal reasons, and will no longer hold any position in the company after his resignation.
On February 5, Gangtong Medical (301515SZ) announced that George Xiaogang applied for resignation as a director of the fourth board of directors of the company due to his busy work, and will no longer hold any position in the company after his resignation.
On February 6, Gloria Ying (002821SZ) announced that due to personal reasons, Wang Qingsong proposed to resign as an independent director of the fourth board of directors, chairman of the remuneration and assessment committee of the board of directors, and a member of the audit committee and nomination committee of the company. After Wang Qingsong's resignation, he no longer held a position in ***.
On February 6, Kangchen Pharmaceutical (603590SH) announced that Zhou Jun applied for resignation as a director of the fourth board of directors of the company due to personal reasons, and will no longer hold any position in the company after his resignation.
On February 7, Yibai Pharmaceutical (600594SH) announced that Lang Hongping applied for resignation as vice chairman, director and co-president of the company due to personal reasons. After his resignation, Mr. Lang Hongping no longer holds any position in the Company.
On February 7, Mingde Biotech (002932SZ) announced that Xu Bo applied for resignation as the company's ** affairs representative for personal reasons, and Zhou Guohui applied for resignation as the company's financial director for personal reasons, and the two will no longer hold any positions in the company and its holding subsidiaries after their resignation.
On February 8, Yunnan Baiyao (000538SZ) announced that Yin Pinyao applied for resignation from the company's chief operating officer, senior vice president and all positions in the company and its holding subsidiaries due to personal reasons; Due to personal reasons, Yu Juan applied for resignation from the company's chief human resources officer and all positions in the company and its holding subsidiaries.
On February 8, Huaren Pharmaceutical (300110SZ) announced that Wu Cong applied for resignation as senior vice president and secretary of the board of directors of the company for personal reasons, and will no longer hold any position in the company after his resignation.
On February 9, Yibai Pharmaceutical (600594SH) announced that Xu Miao applied for resignation from the position of deputy general manager and secretary of the board of directors of the company due to personal reasons. After his resignation, Xu Miao no longer held any position in the company. Before the company formally appoints a new secretary of the board of directors, the board of directors of the company designates Dou Yaqi, vice chairman and general manager of the company, to act as the secretary of the board of directors.
On February 9, Dashenlin (603233SH) announced that director Ke Kangbao applied for resignation as a director of the fourth board of directors of the company, and also resigned as a member of the audit committee of the fourth board of directors and a member of the strategy committee of the fourth board of directors; Director Ke Jinlong applied for resignation as a director of the fourth board of directors of the company, and also resigned as a member of the nomination committee of the fourth board of directors.
Red Star News reporter Deng Lingyao.
Edited by Yang Cheng.
*Red Star News, Newspaper Rewards! ）